fda warning letters compounded semaglutide tirzepatide 2025 US sends 25 to telehealth companies over claims on weight-loss drugs FDA Warns Telehealth Firms Over

After a thorough consultation and reviewing lab work, a personalized weight management program was put into place

This publication has not received compensated access to Omzo's platform, has not undergone a telehealth consultation through Omzo, has not been granted access to internal clinical protocols or pharmacy sourcing documentation, and has not conducted independent testing of any Omzo medication or program component

Licensing and clinical oversight to look for A credible program employs state-licensed clinicians, evaluates each patient before prescribing, and supports dose titration and side-effect management afterward

Rotate between the abdomen, thigh, and upper arm, never injecting within one inch of a previous injection site

(PubMed) Varkal MA, Karabocuoglu M

Naltrexone, originally developed for opioid and alcohol addiction, blocks opioid receptors in the brain's reward pathways